Replies to post #55526 on RespireRx Pharmaceuticals Inc (fka RSPI)

[LTListener]

Agree. This can be that investment and more.

They have indicated for a long time working on strategic deals. Get the funding, grants and resources along with structure in place. Hopefully we start hearing about this over next weeks and months. From there possibly advancing into multiple clinical trials in early 2026 can yield additional milestone benefits, whether in a deal or just value of progression along clinical pathway sets up stronger valuation. I too like the .25-.50 target by end of 2026. Again though any pharma investor knows time is money when it comes to value of a candidate drug.

[LTListener]

Now if we are in to hoping and wishing…

I hope the work with HEAL and ETSP is so “remarkable” that BP would want to strike a huge preclinical deal now before any phase 1 trial. Turn the baton over to someone with the resources to push and who understands time is money. This could accelerate things significantly. Of course the major milestones and valuation leaps are always back loaded towards phase 2 and phase 3 success, but could underpin a huge leap in valuation allowing for more development of entirety of pipeline all being additive.

[leverage102]

RSPI could come out with Game changing developments, and Truly open at a dollar and above. I believe imo RSPI took itself off trading so not to be manipulated. They know what they have, just working on the science and could open at Justifiable number. IMHO.'

[pumper_stumper]

BURNED? You forgot to stick to your script of "I got in at the lows so I have gains there"!

I used to follow the OTC very closely but admittedly have not the past year since getting burned in the ENZC debocle.